APOC 13 PROGRAMME 2024
APOC: MAY 20-24 2024
PROGRAMME
Day 1
Monday May 20
08:30-9:00
Welcome and introduction to 13th Advanced Paediatric Oncology Course 2024
09:15-12:30
MOLECULAR HALLMARKS OF CANCER IN CHILDREN
Chair: Professor Michael Sullivan
09:15 Genetics of Childhood Cancer; an introduction
10:30
Molecular Genetics in Clinical Practice
11:30
Genomics in the design of modern clinical trials:
12:30-13:30 LUNCH
13:30-15:30
PRECISION MEDICINE (Part 1)
Chair: Dr Rebecca Hill
13:30 Precision Medicine: benefits and pitfalls
14:30
CAR-T cells: principles and practice
15:45-16:45
PRECISION MEDICINE (Part 2)
Chair:Professor Simon Bailey
15:45
Molecular Tumour Board: group case discussion and presentation
16:45; DAY 1 Summary and Q&A
19:00 Social Evening - venue to be confirmed
Day 2
Tuesday May 21
09:00-12:30
CLINICAL TRIALS; EVOLUTION AND DESIGN
Chair: Dr Fiona Herd
09:00
Designing Contemporay Clinical Trials
10:30-11:30
IMMUNOTHERAPY (Part 2)
Chair: Dr Fiona Herd
10:30
Basics of Immunotherapy
11:30
Wilms Tumour and Renal Tumours
12:30-13:30 LUNCH
13:30-15:30
PRECISION MEDICINE (Part 3)
Chair: Professor Simon Bailey
13:30
Brain Tumours: Biologically Informed Therapy
14:45
Emerging Therapy for Childhood Brain Tumours
15:45
Molecular Tumour Board: Brain tumour case discussion and presentations
17:00
DAY 2 Summary and Q&A
Day 3
Wednesday May 22
09:00-12:30
PRECISION MEDICINE (Part 4); Bone tumours, Sarcoma and Germ Cell tumours
Chair: Dr Fiona Herd
09:00
Bone Tumours: evolution of therapy and hopes for the future
10:30
Sarcomas: Development of Rhabdomyosarcoma clinical trials and current controversies
11:30
Germ Cell Tumours: biology and new clinical trials
12:30-13:30 LUNCH
13:30-17:00
RISK ADAPTED THERAPY (Part 1): LEUKAEMIA AND LYMPHOMA
Chair: Dr Rebecca Hill
13:30
Molecular-based therapy of ALL
14:30
Non-Hodgkin Lymphoma; the developing molecular landscape and impact on therapy
15:45
Neuroblastoma: biologically informed therapy and clinical trials
16:45
Clinical Case Discussions and Presentations
17:30
DAY 3 Summary and Q&A
Day 4
Thursday May 23
09:00-12:30
LATE EFFECTS AND SURVIVORSHIP (Part 1)
Chair: Professor Simon Bailey
09:00
Long Term Follow UP: its importance and how to develop a service
10:30
Cardio-Oncology; biological markers and cardio-protection
11:30
JON PRICHARD LECTURE
Chair: Professor Michael Sullivan
11:30
JON PRICHARD LECTURE: Biological determinants of Survivorship
12:30-13:30 LUNCH
13:30-14:30
RISK ADAPTED THERAPY: (Part 2): Hepatoblastoma
Chair: Professor Simon Bailey
13:30
Hepatoblastoma; clinical trials, ototoxicity and oto-protection
15:00-17:30
GLOBAL PAEDIATRIC ONCOLOGY
Chair: Professor Michael Sullivan
15:00
The African Experience
16:00 Case Presentations from Resource Limited Settings
16:45 Global Initiatives for Childhood Cancer
20:00 APOC Course Dinner
VENUE: Howies Waterloo Place , 29 Waterloo Place, Edinburgh, www.howies.uk.com
Day 5
Friday May 24
09:00-12:30 Risk Adapted Therapy (Part 3)
Chair: Dr Rebecca Hill
09:00
Early phase trials and emerging models of pallitive care
Dr Quentin Campbell Hewson